163 related articles for article (PubMed ID: 36132041)
1. CTL-doxorubicin (DOX)-gold complex nanoparticles (DOX-AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model.
Liu Q; Liu H; Sacco P; Djaker N; Lamy de la Chapelle M; Marsich E; Li X; Spadavecchia J
Nanoscale Adv; 2020 Nov; 2(11):5231-5241. PubMed ID: 36132041
[TBL] [Abstract][Full Text] [Related]
2. Correction: CTL-doxorubicin (DOX)-gold complex nanoparticles (DOX-AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model.
Liu Q; Liu H; Sacco P; Djaker N; Lamy de la Chapelle M; Marsich E; Li X; Spadavecchia J
Nanoscale Adv; 2022 Oct; 4(21):4701-4702. PubMed ID: 36341290
[TBL] [Abstract][Full Text] [Related]
3. Lactose-Modified Chitosan Gold(III)-PEGylated Complex-Bioconjugates: From Synthesis to Interaction with Targeted Galectin-1 Protein.
Liu Q; Sacco P; Marsich E; Furlani F; Arib C; Djaker N; Lamy de la Chapelle M; Donati I; Spadavecchia J
Bioconjug Chem; 2018 Oct; 29(10):3352-3361. PubMed ID: 30215508
[TBL] [Abstract][Full Text] [Related]
4. Tunable Design of Gold(III)-Doxorubicin Complex-PEGylated Nanocarrier. The Golden Doxorubicin for Oncological Applications.
Moustaoui H; Movia D; Dupont N; Bouchemal N; Casale S; Djaker N; Savarin P; Prina-Mello A; de la Chapelle ML; Spadavecchia J
ACS Appl Mater Interfaces; 2016 Aug; 8(31):19946-57. PubMed ID: 27424920
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic Assessment of Doxorubicin (DOX)-Gemcitabine (GEM) Gold Complex Nanovector as Diagnostic Tool of Galectin-1 Biomarker.
Khan M; Cherni K; Dekhili R; Spadavecchia J
Nanotechnol Sci Appl; 2024; 17():95-105. PubMed ID: 38567312
[TBL] [Abstract][Full Text] [Related]
6. Thermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective Chemoradiotherapy.
Li T; Zhang M; Wang J; Wang T; Yao Y; Zhang X; Zhang C; Zhang N
AAPS J; 2016 Jan; 18(1):146-55. PubMed ID: 26381779
[TBL] [Abstract][Full Text] [Related]
7. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
Elbialy NS; Fathy MM; Khalil WM
Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
[TBL] [Abstract][Full Text] [Related]
9. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
10. Lenalidomide (LENA) Hybrid Gold Complex Nanoparticles: Synthesis, Physicochemical Evaluation, and Perspectives in Nanomedicine.
Arib C; Spadavecchia J
ACS Omega; 2020 Nov; 5(44):28483-28492. PubMed ID: 33195898
[TBL] [Abstract][Full Text] [Related]
11. Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice.
Abo Mansour HE; El-Batsh MM; Badawy NS; Mehanna ET; Mesbah NM; Abo-Elmatty DM
Hum Exp Toxicol; 2020 Nov; 39(11):1528-1544. PubMed ID: 32519553
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
Elbialy NS; Fathy MM; Khalil WM
Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
[TBL] [Abstract][Full Text] [Related]
14. Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration.
Son S; Deepagan VG; Shin S; Ko H; Min J; Um W; Jeon J; Kwon S; Lee ES; Suh M; Lee DS; Park JH
Acta Biomater; 2018 Oct; 79():294-305. PubMed ID: 30134209
[TBL] [Abstract][Full Text] [Related]
15. A tumor-specific cleavable nanosystem of PEG-modified C60@Au hybrid aggregates for radio frequency-controlled release, hyperthermia, photodynamic therapy and X-ray imaging.
Shi J; Chen Z; Wang L; Wang B; Xu L; Hou L; Zhang Z
Acta Biomater; 2016 Jan; 29():282-297. PubMed ID: 26485168
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
[TBL] [Abstract][Full Text] [Related]
17. Collagenase IV and clusterin-modified polycaprolactone-polyethylene glycol nanoparticles for penetrating dense tumor tissues.
Huang HY; Chen LQ; Sun W; Du HH; Dong S; Ahmed AMQ; Cao D; Cui JH; Zhang Y; Cao QR
Theranostics; 2021; 11(2):906-924. PubMed ID: 33391512
[No Abstract] [Full Text] [Related]
18. Improvement of chemotherapy through reducing of cachexia by using Citrus unshiu peel extract.
Tahaghoghi-Hajghorbani S; Ebrahimzadeh MA; Rafiei A; Golpour M; Hosseini-Khah Z; Akhtari J
J Ethnopharmacol; 2019 Oct; 242():111929. PubMed ID: 31054317
[TBL] [Abstract][Full Text] [Related]
19. Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles.
Chen D; Pan X; Xie F; Lu Y; Zou H; Yin C; Zhang Y; Gao J
Int J Nanomedicine; 2018; 13():6855-6870. PubMed ID: 30498347
[TBL] [Abstract][Full Text] [Related]
20. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
